These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20001863)

  • 41. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Brugada Syndrome Susceptibility Gene
    Veerman CC; Podliesna S; Tadros R; Lodder EM; Mengarelli I; de Jonge B; Beekman L; Barc J; Wilders R; Wilde AAM; Boukens BJ; Coronel R; Verkerk AO; Remme CA; Bezzina CR
    Circ Res; 2017 Aug; 121(5):537-548. PubMed ID: 28637782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuation of CHOP-mediated myocardial apoptosis in pressure-overloaded dominant negative p38α mitogen-activated protein kinase mice.
    Sari FR; Widyantoro B; Thandavarayan RA; Harima M; Lakshmanan AP; Zhang S; Muslin AJ; Suzuki K; Kodama M; Watanabe K
    Cell Physiol Biochem; 2011; 27(5):487-96. PubMed ID: 21691066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pivotal Role of Regulator of G-protein Signaling 12 in Pathological Cardiac Hypertrophy.
    Huang J; Chen L; Yao Y; Tang C; Ding J; Fu C; Li H; Ma G
    Hypertension; 2016 Jun; 67(6):1228-36. PubMed ID: 27091895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system.
    Chin MT; Maemura K; Fukumoto S; Jain MK; Layne MD; Watanabe M; Hsieh CM; Lee ME
    J Biol Chem; 2000 Mar; 275(9):6381-7. PubMed ID: 10692439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated myocardial Na+/H+ exchanger isoform 1 activity elicits gene expression that leads to cardiac hypertrophy.
    Xue J; Mraiche F; Zhou D; Karmazyn M; Oka T; Fliegel L; Haddad GG
    Physiol Genomics; 2010 Aug; 42(3):374-83. PubMed ID: 20460605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
    Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
    Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy.
    Johnson KR; Nicodemus-Johnson J; Spindler MJ; Carnegie GK
    PLoS One; 2015; 10(7):e0132474. PubMed ID: 26192751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.
    De Windt LJ; Lim HW; Taigen T; Wencker D; Condorelli G; Dorn GW; Kitsis RN; Molkentin JD
    Circ Res; 2000 Feb; 86(3):255-63. PubMed ID: 10679475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure.
    Schiekofer S; Shiojima I; Sato K; Galasso G; Oshima Y; Walsh K
    Physiol Genomics; 2006 Oct; 27(2):156-70. PubMed ID: 16882883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
    Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
    Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy.
    Buitrago M; Lorenz K; Maass AH; Oberdorf-Maass S; Keller U; Schmitteckert EM; Ivashchenko Y; Lohse MJ; Engelhardt S
    Nat Med; 2005 Aug; 11(8):837-44. PubMed ID: 16025126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy.
    Matsuhashi T; Endo J; Katsumata Y; Yamamoto T; Shimizu N; Yoshikawa N; Kataoka M; Isobe S; Moriyama H; Goto S; Fukuda K; Tanaka H; Sano M
    J Mol Cell Cardiol; 2019 May; 130():122-130. PubMed ID: 30946837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction.
    Hill C; Würfel A; Heger J; Meyering B; Schlüter KD; Weber M; Ferdinandy P; Aronheim A; Schulz R; Euler G
    Cardiovasc Res; 2013 Jul; 99(1):121-8. PubMed ID: 23612584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HSP75 protects against cardiac hypertrophy and fibrosis.
    Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS
    J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Hey2 transcription factor in the early embryonic ventricles is controlled through a distal enhancer by Tbx20 and Gata transcription factors.
    Ihara D; Watanabe Y; Seya D; Arai Y; Isomoto Y; Nakano A; Kubo A; Ogura T; Kawamura T; Nakagawa O
    Dev Biol; 2020 May; 461(2):124-131. PubMed ID: 32035085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulator of G protein signaling 3 protects against cardiac hypertrophy in mice.
    Liu Y; Huang H; Zhang Y; Zhu XY; Zhang R; Guan LH; Tang Q; Jiang H; Huang C
    J Cell Biochem; 2014 May; 115(5):977-86. PubMed ID: 24375609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.